News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,192 Results
Type
Article (2436)
Company Profile (39)
Press Release (35717)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (14119)
Career Advice (77)
Deals (2077)
Drug Delivery (9)
Drug Development (4100)
Employer Resources (10)
FDA (431)
Job Trends (763)
News (20134)
Policy (1052)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (144)
Allergies (6)
Alliances (3473)
ALS (4)
Alzheimer's disease (45)
Antibody-drug conjugate (ADC) (14)
Approvals (432)
Artificial intelligence (12)
Autoimmune disease (3)
Automation (1)
Bankruptcy (12)
Best Places to Work (475)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (29)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (19)
Cancer (142)
Cardiovascular disease (5)
Career advice (64)
Career pathing (1)
CAR-T (15)
Cell therapy (43)
Cervical cancer (2)
Clinical research (3175)
Collaboration (94)
Compensation (48)
COVID-19 (180)
CRISPR (7)
C-suite (28)
Cystic fibrosis (2)
Data (112)
Denatured (3)
Depression (3)
Diabetes (10)
Diagnostics (467)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (15)
Drug pricing (7)
Duchenne muscular dystrophy (12)
Earnings (4235)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6022)
Executive appointments (97)
FDA (477)
Featured Employer (3)
Funding (78)
Gene editing (14)
Gene therapy (18)
GLP-1 (60)
Government (149)
Healthcare (704)
Huntington's disease (3)
IgA nephropathy (3)
Immunology and inflammation (16)
Indications (2)
Infectious disease (185)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (10)
Interviews (7)
IPO (987)
IRA (7)
Job creations (290)
Job search strategy (62)
Kidney cancer (4)
Labor market (4)
Layoffs (37)
Leadership (1)
Legal (212)
Liver cancer (5)
Lung cancer (15)
Lymphoma (3)
Management (4)
Manufacturing (19)
MASH (4)
Medical device (307)
Medtech (307)
Mergers & acquisitions (1160)
Metabolic disorders (34)
Multiple sclerosis (7)
Neurodegenerative disease (9)
Neuropsychiatric disorders (3)
Neuroscience (90)
NextGen: Class of 2025 (352)
Non-profit (153)
Northern California (358)
Now hiring (4)
Obesity (16)
Opinion (15)
Ovarian cancer (10)
Pain (9)
Pancreatic cancer (3)
Parkinson's disease (4)
Partnered (2)
Patents (22)
Patient recruitment (4)
Peanut (1)
People (5661)
Pharmaceutical (5)
Phase I (1372)
Phase II (1591)
Phase III (846)
Pipeline (74)
Policy (12)
Postmarket research (30)
Preclinical (593)
Press Release (2)
Prostate cancer (3)
Psychedelics (2)
Radiopharmaceuticals (12)
Rare diseases (22)
Real estate (420)
Recruiting (5)
Regulatory (803)
Reports (6)
Research institute (142)
Resumes & cover letters (9)
Schizophrenia (10)
Series A (25)
Series B (5)
Service/supplier (2)
Sickle cell disease (1)
Southern California (360)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (489)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
United States (1729)
Vaccines (28)
Venture capitalists (8)
Weight loss (12)
Women's health (1)
Worklife (1)
Date
Today (1)
Last 7 days (49)
Last 30 days (215)
Last 365 days (2563)
2025 (746)
2024 (2617)
2023 (2858)
2022 (3750)
2021 (4048)
2020 (3471)
2019 (2061)
2018 (1554)
2017 (1795)
2016 (1624)
2015 (1833)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (43)
Alabama (1)
Arizona (14)
Asia (1862)
Australia (298)
California (831)
Canada (132)
China (38)
Colorado (20)
Connecticut (10)
Delaware (4)
Europe (3821)
Florida (44)
Georgia (5)
Idaho (3)
Illinois (14)
India (1)
Indiana (32)
Japan (7)
Kansas (12)
Maryland (25)
Massachusetts (301)
Michigan (8)
Minnesota (14)
Missouri (3)
Nebraska (1)
Nevada (3)
New Hampshire (2)
New Jersey (69)
New York (49)
North Carolina (90)
Northern California (358)
Ohio (25)
Oklahoma (2)
Oregon (4)
Pennsylvania (50)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (360)
Tennessee (2)
Texas (71)
Utah (2)
Virginia (6)
Washington D.C. (1)
Washington State (50)
Wisconsin (6)
38,192 Results for "renovaro biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Renovaro Provides Update to Definitive Agreement with Predictive Oncology
April 7, 2025
·
2 min read
Press Releases
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine
April 10, 2025
·
6 min read
Press Releases
Renovaro Announces $15 million in Equity Committed
February 27, 2025
·
2 min read
Press Releases
Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine
February 27, 2025
·
5 min read
Press Releases
Predictive Oncology Announces Agreement to be Acquired by Renovaro
January 6, 2025
·
6 min read
Biotech Beach
Renovaro Biosciences Announces Results of Special Meeting of Shareholders
Renovaro Biosciences Inc. announced today the results of the Company’s Special Meeting of Shareholders held at 12:00 pm ET on January 25, 2024.
January 25, 2024
·
1 min read
Press Releases
Renovaro Appoints Nathen Fuentes as Chief Financial Officer
January 8, 2025
·
3 min read
Press Releases
Renovaro to Acquire Predictive Oncology in All-Stock Transaction
January 6, 2025
·
5 min read
Biotech Beach
AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine
Renovaro Inc. announced that it completed its acquisition of GEDi Cube Intl Ltd. Renovaro, which means renew, combines the power of the AI Health Tech platform of GEDiCube with the advanced cell and gene-therapy Biotech platform of Renovaro Biosciences to accelerate precision, personalized medicine, and a new era in healthcare innovation.
February 13, 2024
·
3 min read
Press Releases
Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV
December 30, 2024
·
5 min read
1 of 3,820
Next
